174 related articles for article (PubMed ID: 20073610)
1. Expression of Galectin-3 in renal neoplasms: a diagnostic, possible prognostic marker.
Dancer JY; Truong LD; Zhai Q; Shen SS
Arch Pathol Lab Med; 2010 Jan; 134(1):90-4. PubMed ID: 20073610
[TBL] [Abstract][Full Text] [Related]
2. Claudin-7 immunohistochemistry in renal tumors: a candidate marker for chromophobe renal cell carcinoma identified by gene expression profiling.
Hornsby CD; Cohen C; Amin MB; Picken MM; Lawson D; Yin-Goen Q; Young AN
Arch Pathol Lab Med; 2007 Oct; 131(10):1541-6. PubMed ID: 17922590
[TBL] [Abstract][Full Text] [Related]
3. Role of carbonic anhydrase IX, α-methylacyl coenzyme a racemase, cytokeratin 7, and galectin-3 in the evaluation of renal neoplasms: a tissue microarray immunohistochemical study.
Bing Z; Lal P; Lu S; Ziober A; Tomaszewski JE
Ann Diagn Pathol; 2013 Feb; 17(1):58-62. PubMed ID: 22898056
[TBL] [Abstract][Full Text] [Related]
4. Expression and Distribution of Galectin-3 in Chromophobe and Papillary Carcinomas.
Cioca A; Muntean D; Bungardean C; Raica M; Cimpean AM
Anticancer Res; 2018 Jan; 38(1):259-263. PubMed ID: 29277781
[TBL] [Abstract][Full Text] [Related]
5. Claudin-7 is highly expressed in chromophobe renal cell carcinoma and renal oncocytoma.
Choi YD; Kim KS; Ryu S; Park Y; Cho NH; Rha SH; Jang JJ; Ro JY; Juhng SW; Choi C
J Korean Med Sci; 2007 Apr; 22(2):305-10. PubMed ID: 17449941
[TBL] [Abstract][Full Text] [Related]
6. Paxillin: application of immunohistochemistry to the diagnosis of chromophobe renal cell carcinoma and oncocytoma.
Kuroda N; Guo L; Toi M; Naruse K; Miyazaki E; Hayashi Y; Yoshikawa C; Ashida S; Shuin T; Enzan H
Appl Immunohistochem Mol Morphol; 2001 Dec; 9(4):315-8. PubMed ID: 11759057
[TBL] [Abstract][Full Text] [Related]
7. Expression of the Na+/K+-transporting ATPase gamma subunit FXYD2 in renal tumors.
Gaut JP; Crimmins DL; Lockwood CM; McQuillan JJ; Ladenson JH
Mod Pathol; 2013 May; 26(5):716-24. PubMed ID: 23196795
[TBL] [Abstract][Full Text] [Related]
8. The MIB-1 tumor proliferation index in adult renal epithelial tumors with granular cytoplasm: biologic implications and differential diagnostic potential.
Tickoo SK; Amin MB; Linden MD; Zarbo RJ
Mod Pathol; 1998 Nov; 11(11):1115-21. PubMed ID: 9831210
[TBL] [Abstract][Full Text] [Related]
9. PAX2 and PAX8 expression in primary and metastatic renal tumors: a comprehensive comparison.
Ozcan A; de la Roza G; Ro JY; Shen SS; Truong LD
Arch Pathol Lab Med; 2012 Dec; 136(12):1541-51. PubMed ID: 23194047
[TBL] [Abstract][Full Text] [Related]
10. Proximal CD13 Versus Distal GATA-3 Expression in Renal Neoplasia According to WHO 2016 Classification.
Brunelli M; Erdini F; Cima L; Eccher A; Fioravanzo A; Gobbo S; Segala D; Ghimenton C; Mazzoleni G; Munari E; Carella R; Martignoni G
Appl Immunohistochem Mol Morphol; 2018; 26(5):316-323. PubMed ID: 27556823
[TBL] [Abstract][Full Text] [Related]
11. C-kit expression in renal oncocytomas and chromophobe renal cell carcinomas.
Huo L; Sugimura J; Tretiakova MS; Patton KT; Gupta R; Popov B; Laskin WB; Yeldandi A; Teh BT; Yang XJ
Hum Pathol; 2005 Mar; 36(3):262-8. PubMed ID: 15791570
[TBL] [Abstract][Full Text] [Related]
12. Expression of galectin-1 and galectin-3 in renal cell carcinoma; immunohistochemical study.
Aboulhagag NA; El-Deek HEM; Sherif MF
Ann Diagn Pathol; 2018 Oct; 36():31-37. PubMed ID: 30055522
[TBL] [Abstract][Full Text] [Related]
13. Immunostaining characteristics of irisin in benign and malignant renal cancers.
Kuloğlu T; Artaş G; Yardim M; Sahin I; Aydin Y; Beyoğlu N; Özercan IH; Yalcin MH; Ugur K; Aydin S
Biotech Histochem; 2019 Aug; 94(6):435-441. PubMed ID: 30896263
[TBL] [Abstract][Full Text] [Related]
14. Prognostic and diagnostic implications of epithelial cell adhesion/activating molecule (EpCAM) expression in renal tumours: a retrospective clinicopathological study of 948 cases using tissue microarrays.
Zimpfer A; Maruschke M; Rehn S; Kundt G; Litzenberger A; Dammert F; Zettl H; Stephan C; Hakenberg OW; Erbersdobler A
BJU Int; 2014 Aug; 114(2):296-302. PubMed ID: 24215118
[TBL] [Abstract][Full Text] [Related]
15. Succinate dehydrogenase B: a new prognostic biomarker in clear cell renal cell carcinoma.
Cornejo KM; Lu M; Yang P; Wu S; Cai C; Zhong WD; Olumi A; Young RH; Wu CL
Hum Pathol; 2015 Jun; 46(6):820-6. PubMed ID: 25827535
[TBL] [Abstract][Full Text] [Related]
16. The diagnostic utility of MOC31, BerEP4, RCC marker and CD10 in the classification of renal cell carcinoma and renal oncocytoma: an immunohistochemical analysis of 328 cases.
Pan CC; Chen PC; Ho DM
Histopathology; 2004 Nov; 45(5):452-9. PubMed ID: 15500648
[TBL] [Abstract][Full Text] [Related]
17. Clear cell renal cell carcinoma: discrimination from other renal cell carcinoma subtypes and oncocytoma at multiphasic multidetector CT.
Young JR; Margolis D; Sauk S; Pantuck AJ; Sayre J; Raman SS
Radiology; 2013 May; 267(2):444-53. PubMed ID: 23382290
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic value of cytokeratin 7 and parvalbumin in differentiating chromophobe renal cell carcinoma from renal oncocytoma.
Adley BP; Papavero V; Sugimura J; Teh BT; Yang XJ
Anal Quant Cytol Histol; 2006 Aug; 28(4):228-36. PubMed ID: 16927643
[TBL] [Abstract][Full Text] [Related]
19. Gene expression analysis of renal carcinoma: adipose differentiation-related protein as a potential diagnostic and prognostic biomarker for clear-cell renal carcinoma.
Yao M; Tabuchi H; Nagashima Y; Baba M; Nakaigawa N; Ishiguro H; Hamada K; Inayama Y; Kishida T; Hattori K; Yamada-Okabe H; Kubota Y
J Pathol; 2005 Feb; 205(3):377-87. PubMed ID: 15682440
[TBL] [Abstract][Full Text] [Related]
20. Expression analysis of kidney-specific cadherin in a wide spectrum of traditional and newly recognized renal epithelial neoplasms: diagnostic and histogenetic implications.
Kuehn A; Paner GP; Skinnider BF; Cohen C; Datta MW; Young AN; Srigley JR; Amin MB
Am J Surg Pathol; 2007 Oct; 31(10):1528-33. PubMed ID: 17895753
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]